Ariel Hirsch, MD, is an associate professor and the director of education of the department of radiation oncology at the Boston University School of Medicine. Since 2005, she has worked with the university, first as an assistant professor. Dr. Hirsch collaborates closely with colleagues to improve prostate cancer treatment and mentors many medical students in cancer research. Her primary clinical interests are genitourinary (most commonly prostate) and breast cancer. Her prostate related research interests include investigating prostate cancer outcomes and devising patient specific radiation treatments with three dimensional prostate modeling. She is the principal investigator on a phase 1/2 study examining the use of radiosurgery for high risk prostate cancer. Her research has resulted in numerous publications and presentations. In 2016 she was named a “Top Doc” by Boston Magazine.
- Boston Medical Center
- Massachusetts General Hospital
- Stony Brook University, MD
- State University of New York at Binghamton, BA
- Published on 4/18/2018
Gunther JR, Jimenez RB, Yechieli RL, Parekh A, Berman AT, Braunstein SE, Hirsch AE, Gillespie EF, Vapiwala N, Thomas CR, Fields EC, Golden DW. Introductory Radiation Oncology Curriculum: Report of a National Needs Assessment and Multi-institutional Pilot Implementation. Int J Radiat Oncol Biol Phys. 2018 Aug 01; 101(5):1029-1038. PMID: 29859794.
- Published on 3/6/2018
Paracha M, Kim KN, Qureshi MM, Shah A, Agarwal A, Sachs T, Sarfaty S, Hirsch AE. Scholarly Impact of Student Participation in Radiation Oncology Research. Int J Radiat Oncol Biol Phys. 2018 Jul 15; 101(4):779-783. PMID: 29748099.
- Published on 3/1/2018
Shah NK, Zehr B, Agarwal A, Gupta A, Hirsch AE. In Reply to Leddy. Int J Radiat Oncol Biol Phys. 2018 Mar 01; 100(3):802-803. PMID: 29413291.
- Published on 12/13/2017
Kan CK, Qureshi MM, Gupta A, Agarwal A, Gignac GA, Bloch BN, Thoreson N, Hirsch AE. Risk factors involved in treatment delays and differences in treatment type for patients with prostate cancer by risk category in an academic safety net hospital. Adv Radiat Oncol. 2018 Apr-Jun; 3(2):181-189. PMID: 29904743.
- Published on 12/6/2017
Khanna S, Kim KN, Qureshi MM, Agarwal A, Parikh D, Ko NY, Rand AE, Hirsch AE. Impact of patient demographics, tumor characteristics, and treatment type on treatment delay throughout breast cancer care at a diverse academic medical center. Int J Womens Health. 2017; 9:887-896. PMID: 29255374.
- Published on 10/13/2017
Shah NK, Zehr B, Agarwal A, Gupta A, Hirsch AE. Review of the First 12 Years of the American Society for Radiation Oncology Political Action Committee. Int J Radiat Oncol Biol Phys. 2018 Feb 01; 100(2):301-305. PMID: 29353651.
- Published on 8/7/2017
Neeley BC, Golden DW, Brower JV, Braunstein SE, Hirsch AE, Mattes MD. Student Perspectives on Oncology Curricula at United States Medical Schools. J Cancer Educ. 2017 Aug 07. PMID: 28782081.
- Published on 5/19/2017
Jain A, Khalid M, Qureshi MM, Georgian-Smith D, Kaplan JA, Buch K, Grinstaff MW, Hirsch AE, Hines NL, Anderson SW, Gallagher KM, Bates DDB, Bloch BN. Stereotactic core needle breast biopsy marker migration: An analysis of factors contributing to immediate marker migration. Eur Radiol. 2017 Nov; 27(11):4797-4803. PMID: 28526892.
- Published on 5/9/2017
Agarwal A, Shah A, Shah B, Koottappillil B, Hirsch AE. The Impact of a Radiation Oncologist led Oncology Curriculum on Medical Student Knowledge. J Cancer Educ. 2017 May 09. PMID: 28488259.
- Published on 4/13/2017
Xiang HF, Lu HM, Efstathiou JA, Zietman AL, De Armas R, Harris K, Bloch BN, Qureshi MM, Keohan S, Hirsch AE. Dosimetric impacts of endorectal balloon in CyberKnife stereotactic body radiation therapy (SBRT) for early-stage prostate cancer. J Appl Clin Med Phys. 2017 05; 18(3):37-43. PMID: 28407345.
View 68 more publications: View full profile at BUMC